SUBSCRIBE TODAY!
Subscribing entitles a reader to complete stories on all topics released as they happen, special features, confidential documents and access to the complete, searchable story archive online back to 2004.
IP-Watch Briefs

Inside Views

Contribute your views! Submit an Inside Views idea to info [at] ip-watch [dot] ch.

We welcome your participation in article and blog comment threads, and other discussion forums, where we encourage you to analyse and react to the content available on the Intellectual Property Watch website.

By participating in discussions or reader forums, or by submitting opinion pieces or comments to articles, blogs, reviews or multimedia features, you are consenting to these rules.

1. You agree that you are fully responsible for the content that you post. You will not knowingly post content that violates the copyright, trademark, patent or other intellectual property right of any third party or which you know is under a confidentiality obligation preventing its publication and that you will request removal of the same should you discover that you have violated this provision. Likewise, you may not post content that is libelous, defamatory, obscene, abusive, that violates a third party's right to privacy, that otherwise violates any applicable local, state, national or international law, that amounts to spamming or that is otherwise inappropriate. You may not post content that degrades others on the basis of gender, race, class, ethnicity, national origin, religion, sexual preference, disability or other classification. Epithets and other language intended to intimidate or to incite violence are also prohibited. Furthermore, you may not impersonate others.

2. You understand and agree that Intellectual Property Watch is not responsible for any content posted by you or third parties. You further understand that IP Watch does not monitor the content posted. Nevertheless, IP Watch may monitor the any user-generated content as it chooses and reserves the right to remove, edit or otherwise alter content that it deems inappropriate for any reason whatever without consent nor notice. We further reserve the right, in our sole discretion, to remove a user's privilege to post content on our site. IP Watch is not in any manner endorsing the content of the discussion forums and cannot and will not vouch for its reliability or otherwise accept liability for it.

3. By submitting any contribution to IP Watch, you warrant that your contribution is your own original work and that you have the right to make it available to IP Watch for all purposes and you agree to indemnify IP Watch, its directors, employees and agents against all damages, legal fees and others expenses that may be incurred by IP Watch as a result of your breach of warranty or of these terms.

4. You further agree not to publish any personal information about yourself or anyone else (for example telephone number or home address). If you add a comment to a blog, be aware that your email address will be apparent.

5. IP Watch will not be liable for any loss including but not limited to the following (whether such losses are foreseen, known or otherwise): loss of data, loss of revenue or anticipated profit, loss of business, loss of opportunity, loss of goodwill or injury to reputation, losses suffered by third parties, any indirect, consequential or exemplary damages.

6. You understand and agree that the discussion forums are to be used only for non-commercial purposes. You may not solicit funds, promote commercial entities or otherwise engage in commercial activity in our discussion forums.

7. You acknowledge and agree that you use and/or rely on any information obtained through the discussion forums at your own risk.

8. For any content that you post, you hereby grant to IP Watch the royalty-free, irrevocable, perpetual, exclusive and fully sub-licensable license to use, reproduce, modify, adapt, publish, translate, create derivative works from, distribute, perform and display such content in whole or in part, world-wide and to incorporate it in other works, in any form, media or technology now known or later developed.

9. These terms and your posts and contributions shall be governed and interpreted in accordance with the laws of Switzerland (without giving effect to conflict of laws principles thereof) and any dispute exclusively settled by the Courts of the Canton of Geneva.

Call For Transparency In The Trans-Pacific Partnership Negotiation

In this post, three US law professors explain a recent call by over 30 legal scholars for the US Trade Representative to increase transparency for the Trans-Pacific Partnership Agreement intellectual property chapter, and their response to Ambassador Kirk’s response that he is “strongly offended” by the suggestion that the negotiation is not adequately transparent already.





Latest Comments

For IPW Subscribers
A guide to Geneva-based public health and intellectual property organisations. Read More >

Monthly Reporter

The Intellectual Property Watch Monthly Reporter, published from 2004 to January 2011, is a 16-page monthly selection of the most important, updated stories and features, plus the People and News Briefs columns.

The Intellectual Property Watch Monthly Reporter is available in an online archive on the IP-Watch website, available for IP-Watch Subscribers.

Access the Monthly Reporter Archive >


Public Health

20/01/2012: Book Calls For Re-Casting Debate Over TRIPS And Medicines Access
16/01/2012: WHO Board Considers Reform, Director Re-Election, Key IP-Related Issues
12/01/2012: Johnson & Johnson Denies Patent Pool Licences For HIV Medicines For The Poor
03/01/2012: Most-Read IP-Watch Posts Of 2011 Tell Story Of International IP Policymaking
14/12/2011: Issues Of Interest To IP Community Abound At WTO Ministerial
14/12/2011: WHO Expert Group To Recommend Binding R&D Treaty Negotiation
13/12/2011: Inside Views: Out Of A Dilemma: Banning The Non-Violation Clause Under TRIPS
10/12/2011: WIPO Patent Committee Agrees To Continue Discussions On All Issues
06/12/2011: WIPO Patent Law Committee Sets Sights On “Balance” Among Member Interests
01/12/2011: WTO General Council Extends Deadline For TRIPS Health Amendment
30/11/2011: India: Novartis Hearing Postponed To February
24/11/2011: IP, Trade And Public Health Leaders Turn A Page In History Together
22/11/2011: Doha+10: MSF Asks, What’s Next For TRIPS And Health?
22/11/2011: WHO Pandemic Advisory Group Adjourns Early
21/11/2011: WHO Announces Members Of Pandemic Influenza Advisory Group
21/11/2011: 10 Years Of TRIPS And Public Health: An Anniversary To Celebrate?
17/11/2011: WHO Advisory Group On Pandemic Flu To Meet Next Week
17/11/2011: WTO Ministers Asked To Send Message On TRIPS Extension For LDCs
17/11/2011: WTO, WHO, WIPO To Discuss TRIPS And Health Declaration
16/11/2011: Global Action To Open Generic Competition For Key AIDS Drug
09/11/2011: CBO: Generics Bill Would Save US $4.8 Billion
08/11/2011: Medicines Patent Pool Responds To Critics Of Gilead Licence
04/11/2011: WHO Board Backs Reform Plan For UN Agency
01/11/2011: WHO’s Chan Pitches UN Agency’s “Staying Power,” Unique Role
01/11/2011: WHO Group Agrees On New Mechanism To Fight Poor-Quality Medicines
27/10/2011: WIPO Re:Search Bridges Public, Private Sectors For Neglected Disease Research
27/10/2011: Revised EPO Patent For Conventional Broccoli Has Public Interest Ramifications
26/10/2011: IP Enforcement Tensions At WTO; Health Amendment Extended Again
25/10/2011: WIPO Re:Search Webpage Goes Live, Shows Sponsors
23/10/2011: WTO IP Committee Addresses Medicines Access, Plain-Packaged Tobacco, ACTA
19/10/2011: WIPO To Launch New Drug R&D Database For Neglected Disease Licences
18/10/2011: WTO Trains Officials On TRIPS Flexibilities For Public Health
17/10/2011: Recommendations For Navigating IP Terrain Emerge From UNITAID Forum
14/10/2011: Inside Views: Trade And Access To Medicines: Things The WTO Should Consider
11/10/2011: Medicines Patent Pool Signs Deal With Indian Generics Producer
03/10/2011: Inside Views: A Response From The Authors Of The Health Impact Fund
26/09/2011: Inside Views: Health Impact Fund – Raising Issues Of Distribution, IP Rights And Alliances
16/09/2011: Questions Arise Over UN Policy On Non-Communicable Diseases And IP Rights
15/09/2011: NCDs Pose Major Threat to Public Health, WHO Reports
14/09/2011: USTR White Paper On Trade In Medicines Raises Questions
14/09/2011: Pharma Executive To Head Gates’ Global Health Program
10/09/2011: “Washington Declaration” Demands Return Of Public Interest In IP Rights
08/09/2011: Still A Long Way To Go For Anti-Counterfeiting Trade Agreement
06/09/2011: Indian Supreme Court To Hear Novartis Challenge To India’s Patent Law
11/08/2011: Alto Funcionário Discute Sobre Renúncia Ao Seu Cargo Na ANVISA, No Brasil, Devido à Política Sobre Patentes
11/08/2011: Top Official Discusses Resignation From Brazil’s ANVISA Over Patent Policy
02/08/2011: Myriad Outcome: Winds Shift Again For Gene Patenting In The US
30/07/2011: EU-India Agreement In WTO Dispute Raises Bar For EU Drug Seizures
21/07/2011: Inside Views: Corporate Self-Interest And Strategic Choices: Gilead Licenses To Medicines Patent Pool
20/07/2011: Parliament Study: ACTA Not Fully In Line With EU Rules